For instance, antibodies and other biologics targeting Plasmodium sporozoites could be engineered for enhanced half-life and transcytosis into dermal tissue, possibly via an FcRn-mediated mechanism, thus increasing the efficacy of malaria vaccines targeting Plasmodium sporozoites. This evidence concerns the gene FCGRT and malaria.